Literature DB >> 6601203

Tissue factor activity of normal and neoplastic cells: quantitation and species specificity.

J L Kadish, K M Wenc, H F Dvorak.   

Abstract

The expression of tissue factor activity was evaluated in homogenates and in intact whole cells from a variety of human and nonhuman cell lines of normal and neoplastic origin. A high degree of species specificity in the interaction of tissue factor with other coagulation factors was observed in guinea pig, rat, mouse, and hamster cells. Tissue factor was present in significant amounts in homogenates of both the normal and neoplastic cells tested in all four species examined. No correlation was observed between the amount of tissue factor detected in cell homogenates and the derivation of the cell line from normal versus neoplastic tissue. Intact cells also expressed tissue factor activity, but lower levels were found in most cell lines examined. The significance of these data is discussed with regard to fibrin deposition around tumors in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601203

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

2.  Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.

Authors:  M Szczepański; K Bardadin; J Zawadzki; W Pypno
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 3.  Long-term expression of canine FVIIa in hemophilic dogs.

Authors:  Paris Margaritis
Journal:  Thromb Res       Date:  2010-02-10       Impact factor: 3.944

4.  DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formation.

Authors:  B Casali; M G Lampugnani; M Riganti; A Niewiarowska; G Alessio; L Mussoni; N Semeraro; M B Donati
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

5.  Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.

Authors:  Paris Margaritis; Valder R Arruda; Majed Aljamali; Rodney M Camire; Alexander Schlachterman; Katherine A High
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 6.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

7.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

Authors:  B M Mueller; R A Reisfeld; T S Edgington; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.

Authors:  A S Adamson; P Luckert; M Pollard; M E Snell; M Amirkhosravi; J L Francis
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

9.  Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line.

Authors:  T A Drake; W Ruf; J H Morrissey; T S Edgington
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.